MLYS
Mineralys Therapeutics, Inc.
Company overview
- Market capitalization
- $2.27B
- Employees
- 76
- Latest publication
- 2026-09-29
About Mineralys Therapeutics, Inc.
Mineralys Therapeutics, Inc., a biopharmaceutical company, develops medicines to target diseases driven by dysregulated aldosterone in the United States. It is developing lorundrostat, a proprietary, orally administered, highly selective aldosterone synthase inhibitor for the treatment of cardiorenal conditions affected by dysregulated aldosterone, such as hypertension, chronic kidney disease, and obstructive sleep apnea. The company was formerly known as Catalys SC1, Inc. and changed its name to Mineralys Therapeutics, Inc. in May 2020. Mineralys Therapeutics, Inc. was incorporated in 2019 and is headquartered in Radnor, Pennsylvania.
Financial statements
Income Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 0USD | 0USD | 34,000USD | 0USD | 0USD |
| Cost Of Revenue | 6,000USD | 13,000USD | 15,000USD | 16,000USD | 15,000USD | 17,000USD | 11,000USD | 9,000USD |
| Gross Profit | -6,000USD | -13,000USD | -15,000USD | -16,000USD | -15,000USD | 17,000USD | -11,000USD | -9,000USD |
| Research Development | 24,365,000USD | 24,402,000USD | 31,450,000USD | 38,278,000USD | 37,879,000USD | 44,569,000USD | 53,985,000USD | 39,273,000USD |
| Selling General Administrative | 20,975,000USD | 13,878,000USD | 9,681,000USD | 8,468,000USD | 6,568,000USD | 7,198,000USD | 6,121,000USD | 5,895,000USD |
| Total Operating Expenses | 45,340,000USD | 38,280,000USD | 41,116,000USD | 46,746,000USD | 44,447,000USD | 51,767,000USD | 60,106,000USD | 45,168,000USD |
| Operating Income | -45,340,000USD | -38,280,000USD | -41,131,000USD | -46,746,000USD | -44,447,000USD | -51,767,000USD | -60,106,000USD | -45,168,000USD |
| Interest Income | 5,996,000USD | 6,045,000USD | 4,195,000USD | 3,474,000USD | 2,239,000USD | 2,809,000USD | 3,774,000USD | 4,152,000USD |
| Net Interest Income | 5,996,000USD | 6,045,000USD | 4,195,000USD | 3,474,000USD | 2,239,000USD | 2,809,000USD | 3,774,000USD | 4,152,000USD |
| Income Before Tax | -39,339,000USD | -32,234,000USD | -36,932,000USD | -43,274,000USD | -42,211,000USD | -48,946,000USD | -56,342,000USD | -41,014,000USD |
| Net Income | -39,339,000USD | -32,234,000USD | -36,932,000USD | -43,274,000USD | -42,211,000USD | -48,946,000USD | -56,342,000USD | -41,014,000USD |
| Net Income From Continuing Ops | -39,339,000USD | -32,234,000USD | -36,932,000USD | -43,274,000USD | -42,211,000USD | -48,946,000USD | -56,342,000USD | -41,014,000USD |
| Ebit | -45,346,000USD | -38,280,000USD | -36,932,000USD | -46,746,000USD | -44,447,000USD | -51,767,000USD | -60,106,000USD | -45,168,000USD |
| Ebitda | -45,340,000USD | -38,267,000USD | -36,917,000USD | -46,730,000USD | -44,432,000USD | -51,752,000USD | -60,095,000USD | -45,159,000USD |
| Depreciation And Amortization | 6,000USD | 13,000USD | 15,000USD | 16,000USD | 15,000USD | 15,000USD | 11,000USD | 9,000USD |
| Reconciled Depreciation | 6,000USD | 13,000USD | 15,000USD | 16,000USD | 15,000USD | 15,000USD | 11,000USD | 9,000USD |
| Total Other Income Expense Net | 6,001,000USD | 6,046,000USD | 4,199,000USD | 3,472,000USD | 2,236,000USD | 2,821,000USD | 3,764,000USD | 4,154,000USD |
| Selling And Marketing Expenses | — | — | — | — | — | — | — | 9,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD |
|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Cost Of Revenue | 59,000USD | 43,000USD | — | — | — | — |
| Gross Profit | -59,000USD | -43,000USD | — | — | — | — |
| Research Development | 132,009,000USD | 168,581,000USD | 70,361,000USD | 26,250,000USD | 16,308,000USD | 2,411,000USD |
| Selling General Administrative | 38,595,000USD | 23,822,000USD | 14,296,000USD | 5,229,000USD | 2,417,000USD | 532,000USD |
| Total Operating Expenses | 170,604,000USD | 192,403,000USD | 84,657,000USD | 31,479,000USD | 18,725,000USD | 2,943,000USD |
| Operating Income | -170,604,000USD | -192,403,000USD | -84,657,000USD | -31,479,000USD | -18,725,000USD | -2,943,000USD |
| Interest Income | 15,953,000USD | 14,588,000USD | 10,370,000USD | 1,676,000USD | — | — |
| Net Interest Income | 15,953,000USD | 14,588,000USD | 10,370,000USD | 1,676,000USD | -27,000USD | -115,000USD |
| Income Before Tax | -154,651,000USD | -177,810,000USD | -71,898,000USD | -29,799,000USD | -19,408,000USD | -3,426,000USD |
| Net Income | -154,651,000USD | -177,810,000USD | -71,898,000USD | -29,799,000USD | -19,408,000USD | -3,426,000USD |
| Net Income From Continuing Ops | -154,651,000USD | -177,810,000USD | -56,582,000USD | -29,799,000USD | -19,408,000USD | -3,426,000USD |
| Ebit | -170,604,000USD | -192,403,000USD | -84,824,895USD | -31,479,000USD | -37,449,000USD | -5,887,000USD |
| Ebitda | -170,545,000USD | -192,360,000USD | -84,657,000USD | -31,479,000USD | -19,381,000USD | -3,311,000USD |
| Depreciation And Amortization | 59,000USD | 43,000USD | 167,895USD | 228,485USD | 18,725,000USD | 2,943,000USD |
| Reconciled Depreciation | 59,000USD | 43,000USD | 0USD | — | — | — |
| Total Other Income Expense Net | 15,953,000USD | 14,593,000USD | 12,759,000USD | 4,000USD | -683,000USD | -483,000USD |
| Income Tax Expense | — | -177,810,000USD | -167,895USD | -1,904,485USD | 27,000USD | 115,000USD |
| Interest Expense | — | — | — | 1,676,000USD | 27,000USD | 115,000USD |
| Net Income Applicable To Common Shares | — | — | — | -29,799,000USD | -19,408,000USD | -3,426,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 667,853,000USD | 652,862,000USD | 661,806,000USD | 599,947,000USD | 335,724,000USD | 354,941,000USD | 205,903,000USD | 268,253,000USD |
| Cash And Equivalents | 138,268,000USD | — | — | — | — | — | — | — |
| Total Current Assets | 665,802,000USD | 652,470,000USD | 661,386,000USD | 599,796,000USD | 335,269,000USD | 354,506,000USD | 205,351,000USD | 267,732,000USD |
| Other Current Assets | 4,390,000USD | 6,410,000USD | 4,751,000USD | 382,199,000USD | 10,353,000USD | 11,480,000USD | 7,164,000USD | 4,129,000USD |
| Other Non Current Assets | 2,024,000USD | — | — | — | — | — | — | — |
| Total Liabilities | 116,936,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 19,319,000USD | 14,718,000USD | 15,113,000USD | 23,520,000USD | 22,173,000USD | 13,386,000USD | 14,646,000USD | 31,321,000USD |
| Other Current Liabilities | 18,253,000USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | 550,917,000USD | 638,144,000USD | 646,693,000USD | 576,427,000USD | 313,551,000USD | 341,555,000USD | 191,257,000USD | 236,932,000USD |
| Total Equity Including Noncontrolling Interest | 550,917,000USD | — | — | — | — | — | — | — |
| Property Plant Equipment Net | 27,000USD | 32,000USD | 38,000USD | 7,000USD | 22,000USD | 38,000USD | 53,000USD | 69,000USD |
| Accounts Payable | 1,066,000USD | 1,116,000USD | 2,017,000USD | 1,121,000USD | 3,164,000USD | 373,000USD | 479,000USD | 3,106,000USD |
| Common Stock | 9,000USD | 8,000USD | 8,000USD | 8,000USD | 6,000USD | 6,000USD | 5,000USD | 5,000USD |
| Retained Earnings | -737,579,000USD | -496,508,000USD | -457,169,000USD | -424,935,000USD | -388,003,000USD | -344,729,000USD | -302,518,000USD | -253,572,000USD |
| Total Liab | — | 14,718,000USD | 15,113,000USD | 23,520,000USD | 22,173,000USD | 13,386,000USD | 14,646,000USD | 31,321,000USD |
| Other Current Liab | — | 13,602,000USD | 13,096,000USD | 22,399,000USD | 19,009,000USD | 13,013,000USD | 14,167,000USD | 28,215,000USD |
| Capital Stock | — | 8,000USD | 8,000USD | 8,000USD | 6,000USD | 6,000USD | 5,000USD | 5,000USD |
| Cash | — | 112,779,000USD | 172,921,000USD | 217,597,000USD | 101,788,000USD | 165,007,000USD | 114,091,000USD | 97,274,000USD |
| Cash And Short Term Investments | — | 646,060,000USD | 656,635,000USD | 217,597,000USD | 324,916,000USD | 343,026,000USD | 198,187,000USD | 263,603,000USD |
| Net Debt | — | -112,779,000USD | -172,921,000USD | -217,597,000USD | -101,788,000USD | -165,007,000USD | -114,091,000USD | -97,274,000USD |
| Short Term Investments | — | 533,280,999USD | 483,714,000USD | 376,031,000USD | 223,128,000USD | 178,019,000USD | 84,096,000USD | 166,329,000USD |
| Common Stock Shares Outstanding | — | 82,834,752shares | 80,545,736shares | 70,594,504shares | 65,451,297shares | 53,163,551shares | 49,957,912shares | 49,815,185shares |
| Non Current Assets Total | — | 391,999USD | 420,000USD | 151,000USD | 455,000USD | 435,000USD | 552,000USD | 521,000USD |
| Non Current Liabilities Total | — | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Non Currrent Assets Other | — | 359,999USD | 382,000USD | 144,000USD | 433,000USD | 397,000USD | 499,000USD | 452,000USD |
| Net Working Capital | — | 637,752,000USD | 646,273,000USD | 576,276,000USD | 313,096,000USD | 341,120,000USD | 190,705,000USD | 236,411,000USD |
| Unclassified Equity | — | 1,134,636,000USD | 1,103,846,000USD | 1,001,346,000USD | 701,542,000USD | 686,272,000USD | 493,765,000USD | 490,494,000USD |
| Unclassified Current Assets | — | — | — | -376,031,000USD | — | — | — | — |
| Long Term Investments | — | — | — | — | — | — | 0USD | 0USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD |
|---|---|---|---|---|---|---|
| Total Assets | 661,806,000USD | 205,903,000USD | 251,636,000USD | 114,442,000USD | 11,125,000USD | 1,486,000USD |
| Other Current Assets | 4,751,000USD | 7,164,000USD | 12,536,000USD | 2,701,000USD | 510,000USD | 57,000USD |
| Total Liab | 15,113,000USD | 14,646,000USD | 10,482,000USD | 166,711,000USD | 34,050,000USD | 5,083,000USD |
| Total Stockholder Equity | 646,693,000USD | 191,257,000USD | 241,154,000USD | -52,269,000USD | -22,925,000USD | -3,597,000USD |
| Other Current Liab | 13,096,000USD | 14,167,000USD | 9,881,000USD | 6,160,000USD | 4,291,000USD | 54,000USD |
| Common Stock | 8,000USD | 5,000USD | 4,000USD | 1,000USD | 1,000USD | 1,000USD |
| Capital Stock | 8,000USD | 5,000USD | 4,000USD | 1,000USD | 1,000USD | 1,000USD |
| Retained Earnings | -457,169,000USD | -302,518,000USD | -124,708,000USD | -52,810,000USD | -23,011,000USD | -3,603,000USD |
| Cash | 172,921,000USD | 114,091,000USD | 49,304,000USD | 87,701,000USD | 10,612,000USD | 1,409,000USD |
| Cash And Short Term Investments | 656,635,000USD | 198,187,000USD | 236,567,000USD | 110,110,000USD | 10,612,000USD | 1,409,000USD |
| Total Current Assets | 661,386,000USD | 205,351,000USD | 249,103,000USD | 112,811,000USD | 11,122,000USD | 1,466,000USD |
| Total Current Liabilities | 15,113,000USD | 14,646,000USD | 10,482,000USD | 8,067,000USD | 5,054,000USD | 5,083,000USD |
| Net Debt | -172,921,000USD | -114,091,000USD | -49,304,000USD | -87,701,000USD | -10,612,000USD | 3,091,000USD |
| Short Term Investments | 483,714,000USD | 84,096,000USD | 187,263,000USD | 22,409,000USD | 0USD | — |
| Accounts Payable | 2,017,000USD | 479,000USD | 601,000USD | 1,907,000USD | 763,000USD | 529,000USD |
| Property Plant Equipment Net | 38,000USD | 53,000USD | 0USD | — | — | — |
| Common Stock Shares Outstanding | 67,656,355shares | 48,539,795shares | 36,188,254shares | 5,167,296shares | 4,984,286shares | 4,630,487shares |
| Non Current Assets Total | 420,000USD | 552,000USD | 2,533,000USD | 1,631,000USD | 3,000USD | 20,000USD |
| Non Current Liabilities Total | 0USD | 0USD | 0USD | 158,644,000USD | 28,996,000USD | 0USD |
| Non Currrent Assets Other | 382,000USD | 499,000USD | 51,000USD | 1,631,000USD | 3,000USD | 20,000USD |
| Net Working Capital | 646,273,000USD | 190,705,000USD | 238,621,000USD | 104,744,000USD | 6,068,000USD | -3,617,000USD |
| Unclassified Equity | 1,103,846,000USD | 493,765,000USD | 617,490,000USD | 159,183,000USD | — | — |
| Long Term Investments | — | 0USD | 2,482,000USD | 0USD | — | — |
| Other Assets | — | — | 1USD | 0USD | 3,000USD | 20,000USD |
| Accumulated Other Comprehensive Income | — | — | -251,636,000USD | -158,644,000USD | 0USD | 0USD |
| Deferred Long Term Liab | — | — | — | 1,631,000USD | 3,000USD | — |
| Net Tangible Assets | — | — | — | -52,269,000USD | -22,925,000USD | -3,597,000USD |
| Unclassified Non Current Liabilities | — | — | — | 157,013,000USD | 28,993,000USD | — |
| Short Term Debt | — | — | — | — | — | 4,500,000USD |
| Short Long Term Debt | — | — | — | — | — | 4,500,000USD |
| Short Long Term Debt Total | — | — | — | — | — | 4,500,000USD |
| Unclassified Current Liabilities | — | — | — | — | — | -4,500,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -39,339,000USD | -32,234,000USD | -36,932,000USD | -43,274,000USD | -42,211,000USD | -48,946,000USD | -56,342,000USD | -41,014,000USD |
| Depreciation | 6,000USD | 13,000USD | 15,000USD | 16,000USD | 15,000USD | 15,000USD | 11,000USD | 9,000USD |
| Stock Based Compensation | 6,548,000USD | 5,285,000USD | 5,841,000USD | 4,553,000USD | 3,645,000USD | 3,134,000USD | 3,139,000USD | 2,872USD |
| Other Non Cash Items | 1,923,000USD | -4,208,000USD | -2,396,000USD | -2,229,000USD | -1,046,000USD | -1,337,000USD | -2,712,000USD | 22,128USD |
| Change To Account Receivables | 289,000USD | -181,000USD | 10,000USD | -47,000USD | — | 98,000USD | 23,000USD | 184,000USD |
| Change In Working Capital | -2,061,000USD | -6,744,000USD | 4,600,000USD | 10,765,000USD | -5,890,000USD | -19,709,000USD | 5,718,000USD | 10,834,000USD |
| Total Cash From Operating Activities | -39,471,000USD | -37,888,000USD | -28,872,000USD | -30,169,000USD | -45,487,000USD | -66,843,000USD | -50,186,000USD | -30,146,000USD |
| Capital Expenditures | 0USD | -15,000USD | 0USD | 0USD | 0USD | 0USD | -37,000USD | 0USD |
| Free Cash Flow | -39,471,000USD | -37,903,000USD | -28,872,000USD | -30,169,000USD | -45,487,000USD | -66,843,000USD | -50,223,000USD | -30,146,000USD |
| Investments | -44,943,000USD | -103,474,000USD | -150,507,000USD | -42,881,000USD | -92,876,000USD | 83,570,000USD | 79,605,000USD | 7,736,000USD |
| Total Cashflows From Investing Activities | -44,943,000USD | -103,489,000USD | -150,507,000USD | -42,881,000USD | -92,876,000USD | 83,570,000USD | 79,605,000USD | 7,736,000USD |
| Total Cash From Financing Activities | 24,272,000USD | 96,701,000USD | 295,188,000USD | 9,831,000USD | 189,279,000USD | 90,000USD | -1,000USD | -152,000USD |
| Issuance Of Capital Stock | 20,218,000USD | 91,945,000USD | 288,593,000USD | 8,657,000USD | 189,166,000USD | 0USD | 0USD | -60,000USD |
| Change In Cash | -60,142,000USD | -44,676,000USD | 115,809,000USD | -63,219,000USD | 50,916,000USD | 16,817,000USD | 29,418,000USD | -22,562,000USD |
| Begin Period Cash Flow | 172,921,000USD | 217,597,000USD | 101,788,000USD | 165,007,000USD | 114,091,000USD | 97,274,000USD | 67,856,000USD | 90,418,000USD |
| End Period Cash Flow | 112,779,000USD | 172,921,000USD | 217,597,000USD | 101,788,000USD | 165,007,000USD | 114,091,000USD | 97,274,000USD | 67,856,000USD |
| Other Cashflows From Financing Activities | 24,272,000USD | 96,701,000USD | 6,595,000USD | 9,831,000USD | 113,000USD | 90,000USD | -1,000USD | -92,000USD |
| Unclassified Operating Cash Flow | -6,548,000USD | — | — | — | — | — | — | — |
| Unclassified Financing Cash Flow | -20,218,000USD | — | — | — | — | — | — | — |
| Sale Purchase Of Stock | — | 101,000USD | — | 142,000USD | — | — | 138,000USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD |
|---|---|---|---|---|---|---|
| Net Income | -154,651,000USD | -177,810,000USD | -71,898,000USD | -29,799,000USD | -19,408,000USD | -3,426,000USD |
| Depreciation | 59,000USD | 43,000USD | 0USD | — | — | — |
| Stock Based Compensation | 19,324,000USD | 11,336,000USD | 5,060,000USD | 455,000USD | 80,000USD | 1,000USD |
| Other Non Cash Items | -9,879,000USD | -9,405,000USD | -6,865,000USD | -649,000USD | 684,000USD | 482,000USD |
| Change To Account Receivables | -166,000USD | 424,000USD | -355,000USD | — | — | — |
| Change In Working Capital | 2,731,000USD | 9,522,000USD | -7,470,000USD | 772,000USD | 4,085,000USD | 480,000USD |
| Total Cash From Operating Activities | -142,416,000USD | -166,314,000USD | -81,173,000USD | -29,221,000USD | -14,559,000USD | -2,463,000USD |
| Capital Expenditures | -15,000USD | -96,000USD | 0USD | 0USD | 0USD | 0USD |
| Free Cash Flow | -142,431,000USD | -166,410,000USD | -81,173,000USD | -29,221,000USD | -14,559,000USD | -2,463,000USD |
| Investments | -389,738,000USD | 114,959,000USD | -102,383,000USD | -21,759,000USD | -21,759,000USD | -21,759,000USD |
| Total Cashflows From Investing Activities | -389,753,000USD | 114,959,000USD | -160,472,000USD | -21,759,000USD | -21,759,000USD | -21,759,000USD |
| Total Cash From Financing Activities | 590,999,000USD | 116,142,000USD | 203,248,000USD | 128,019,000USD | 23,812,000USD | 3,830,000USD |
| Sale Purchase Of Stock | 243,000USD | 221,000USD | 64,000USD | -1,629,000USD | — | -20,000USD |
| Issuance Of Capital Stock | 578,361,000USD | 116,059,000USD | 202,990,000USD | 129,648,000USD | 23,812,000USD | — |
| Change In Cash | 58,830,000USD | 64,787,000USD | -38,397,000USD | 77,039,000USD | 9,253,000USD | 1,409,000USD |
| Begin Period Cash Flow | 114,091,000USD | 49,304,000USD | 87,701,000USD | 10,662,000USD | 1,409,000USD | 42,000USD |
| End Period Cash Flow | 172,921,000USD | 114,091,000USD | 49,304,000USD | 87,701,000USD | 10,662,000USD | 1,409,000USD |
| Other Cashflows From Financing Activities | 590,999,000USD | 83,000USD | 258,000USD | 129,648,000USD | 23,812,000USD | -20,000USD |
| Unclassified Financing Cash Flow | — | 115,838,000USD | 202,926,000USD | — | -23,812,000USD | 3,850,000USD |
| Unclassified Investing Cash Flow | — | — | -58,089,000USD | — | — | — |
| Change To Liabilities | — | — | — | 3,012,000USD | 4,471,000USD | 537,000USD |
| Other Cashflows From Investing Activities | — | — | — | -21,759USD | — | — |
| Net Borrowings | — | — | — | — | 0USD | 3,850,000USD |
| Dividends Paid | — | — | — | — | — | -3,830,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
No revenue breakdown is currently published for this company.
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.